Search Results 871-880 of 25630 for treatment resistant depression
Participation eligibility · Diagnosis of CD30+ classical Hodgkin lymphoma reconfirmed by histopathology. · Relapsed or refractory disease after standard therapy ...
Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients with Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom ...
177Lu-DTPA-Omburtamab Radioimmunotherapy toTreat Recurrent or Refractory Medulloblastoma · Overview · Participation eligibility · More information · Additional ...
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases. Prostate. 2022 Sep; 82 ...
Explain that depression is a complex condition — not a personal flaw or weakness — and that effective treatment exists. Suggest seeking help from a health care ...
Read more about depression and caffeine. Oral health: Brush up on Dental Care Basics · Mayo Clinic Radio: Stem Cell Transplant/Head Lice/Handwashing. Related ...
The purpose of this study is to characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
When you are anxious or depressed, Dr. Bright says, it's important to do the opposite of what you're feeling up to, to take care of yourself. He says don't ...
The purpose of this study is to evaluate if Vancomycin Resistant Enterococci (VRE) can be eradicated in patients with Clostridium Difficile infection (CDI) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.